Characterization of Cell-mediated and Humoral immune responses to a multi-valent #Combination# vaccine in na#ve ponies.

Grants and Contracts Details

StatusFinished
Effective start/end date5/1/13 → 6/30/14

Funding

  • Boehringer-Ingelheim: $51,370.00